Emparan, C <br/><br/>
Calcineurin-free protocols with basiliximab induction allow patients included in "old to old" programs achieve standard kidney transplant function.  [electronic resource] 

 -  Transplantation proceedings  Jun 2003 
 - 1326-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(03)00379-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Age Factors<br/>Antibodies, Monoclonal--therapeutic use<br/>Basiliximab<br/>Calcineurin--physiology<br/>Creatinine--blood<br/>Cyclosporine--therapeutic use<br/>Drug Therapy, Combination<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--immunology<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Recombinant Fusion Proteins<br/>Tissue Donors--statistics & numerical data